Concepedia

Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial

Volkmar Müller, Stephan Gade, Bettina Steinbach, Sibylle Loibl, Gϋnter von Minckwitz, Michael Untch, Kathrin Schwedler, Kristina Lübbe, Christian Schem, Peter A. Fasching,

Breast Cancer Research and Treatment · 2014 · 121 citations · 21 references

DOI

Concepts

References

21

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)

Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei et al. · JNCI Journal of the National Cancer Institute · 2005 · 2.1K citations · Full text

, , +16

Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma

Charles H. Lawrie, Shira Gal, Heather M. Dunlop et al. · British Journal of Haematology · 2008 · 1.7K citations

, , +17

Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

Aman U. Buzdar, Nuhad K. Ibrahim, Deborah Francis et al. · Journal of Clinical Oncology · 2005 · 1.2K citations · Full text

, , +17

The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis

Qihong Huang, Kiranmai Gumireddy, Mariëtte Schrier et al. · Nature Cell Biology · 2008 · 968 citations

, , +12

MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

Cherie Blenkiron, Leonard D. Goldstein, Natalie Thorne et al. · Genome biology · 2007 · 949 citations · Full text

, , +17